Men who seek treatment at a multidisciplinary prostate cancer clinic are more likely to be advised about treatment choices and to receive care that complies with evidence-based treatment guidelines, an MD Anderson Cancer Center study found.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
